| Literature DB >> 34209993 |
Sabrina van Heukelum1,2, Femke E Geers1,2, Kerli Tulva1,2, Sanne van Dulm1,2, Christian F Beckmann1,2, Jan K Buitelaar1,2, Jeffrey C Glennon1,2,3, Brent A Vogt4,5, Martha N Havenith1,2,6, Arthur S C França1,2.
Abstract
Pathological aggression is a debilitating feature of many neuropsychiatric disorders, and cingulate cortex is one of the brain areas centrally implicated in its control. Here we explore the specific role of midcingulate cortex (MCC) in the development of pathological aggression. To this end, we investigated the structural and functional degeneration of MCC in the BALB/cJ strain, a mouse model for pathological aggression. Compared to control animals from the BALB/cByJ strain, BALB/cJ mice expressed consistently heightened levels of aggression, as assessed by the resident-intruder test. At the same time, immunohistochemistry demonstrated stark structural degradation in the MCC of aggressive BALB/cJ mice: Decreased neuron density and widespread neuron death were accompanied by increased microglia and astroglia concentrations and reactive astrogliosis. cFos staining indicated that this degradation had functional consequences: MCC activity did not differ between BALB/cJ and BALB/cByJ mice at baseline, but unlike BALB/cByJ mice, BALB/cJ mice failed to activate MCC during resident-intruder encounters. This suggests that structural and functional impairments of MCC, triggered by neuronal degeneration, may be one of the drivers of pathological aggression in mice, highlighting MCC as a potential key area for pathologies of aggression in humans.Entities:
Keywords: aggression; astrogliosis; cFos; cingulate cortex; neuronal degeneration; resident-intruder test
Year: 2021 PMID: 34209993 PMCID: PMC8301779 DOI: 10.3390/brainsci11070868
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Figure 1Behavioral metrics of aggression: (a) Schematic of the RI test. Testing started with a 5 min instigation phase (mice separated by a glass screen), followed by a 5 min interaction phase; (b) Average attack latency, total number of bites, tail rattles, species-typical bites, and species-atypical bites. Black dots, BALB/cJ mice; gray dots, BALB/cByJ mice. Shown are average (red line), 95% confidence interval (dark gray area), and 1 SD (light gray area). # p < 0.1, * p < 0.05; ** p < 0.01.
Figure 2MCC histology: (a) Schematic of area MCC. Inset: photographs in different magnifications show the outlines of the position of layers. Pyknotic neurons are noted with red arrows in the high-magnification BALB/cJ case. There are also 2 black arrows in layer II to emphasize places where there are clearings with no neurons to emphasize their loss. Scale bars, 100 μm; (b) The proportion of pyknotic/non-pyknotic neurons. Black line, BALB/cJ mice; gray line, BALB/cByJ mice. Shown are average and SEM per layer; (c) The number of neurons per mm2. Shown are average and SEM per layer. * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 3Histological measures in BALB/cJ animals with and without RI test: (a) Proportion pyknotic neurons/healthy neurons in MCC of BALB/cJ mice that participated in the RI (N = 9) test versus those that did not (N = 6). Shown are average and SEM; (b) Same as a for neuron density per mm2; (c) Same as a for microglia per mm2; (d) Same as a for S100B positive astroglia per mm2; (e) Same as a for GFAP positive astroglia per mm2; (f) Same as a for percentage toxic astroglia. None of the comparisons are significant.
Figure 4Microglia and astroglia across MCC layers: (a) Example photograph of a NeuN stained section at low magnification; rectangle shows the area of the zoom-in. Zoom-in: High-magnification photograph of a NeuN section with layers delineated. Scale bar: 100 μm; (b) Left and center panel: Example photograph of microglia across layers (left: BALB/cByJ, center: BALB/cJ); Right panel: Number of microglia per mm2 across layers. Black line, BALB/cJ; gray line, BALB/cByJ; (c) Same as (b) for S100B-positive stained astroglia across layers; (d) Same as (b) for GFAP-positive stained astroglia; (e) Left and center panel: Example photographs of S100B astroglia double stained with a marker for toxic astroglia (Serping1, yellow arrow); Right: The percentage of toxic astroglia. All right-hand panels show average and SEM. # p < 0.1, ** p < 0.01; *** p < 0.001.
Figure 5cFos activity levels: (a) Example photographs of stained cFos cells in BALB/cByJ and BALB/cJ mice, scale bar: 100 μm; (b) The number of cFos-labeled cells per mm2 at baseline. Black line, BALB/cJ mice; gray line, BALB/cByJ mice; (c) The number of cFos-labeled cells per mm2 during the last day of the RI test. Asterisks: Statistical significance of comparison between BALB/cByJ and BALB/cJ mice; (d) Same as (b) but expressed as percentage of total neuron density; (e) Comparison of activity at baseline versus RI for BALB/cJ and BALB/cByJ mice, respectively. Gray asterisks: Statistical comparison between baseline and RI test in BALB/cByJ animals. Black asterisk: Same for BALB/cJ; (b–e) Show the average and SEM per layer. * p < 0.05; ** p < 0.01; *** p < 0.001.